Barbara Langen
8Patents
4h-index
20Co-inventors
53Inventor score
Filing activity: May 24, 2007 → Dec 17, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9981950B2 | Triazoles as NR2B receptor inhibitors | Chemistry; Metallurgy | 17 | Active |
| US10155727B2 | Pyrazoles | Chemistry; Metallurgy | 15 | Active |
| US10323021B2 | Triazoles as NR2B receptor inhibitors | Chemistry; Metallurgy | 13 | Active |
| US9085584B2 | Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders | Chemistry; Metallurgy | 5 | Active |
| US7550465B2 | Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them | Human Necessities | 4 | Active |
| US7875618B2 | Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders | Human Necessities | 3 | Active |
| US9540379B2 | (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases | Human Necessities | 0 | Active |
| USRE49517E1 | Pyrazoles | General | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.